Example: bachelor of science

平成 28 30 - pmda.go.jp

← Back to document page

審査報告書平成29 年1 月18 日独立行政法人医薬品医療機器総合機構承認申請のあった下記の医薬品にかかる医薬品医療機器総合機構での審査結果は、以下のとおりであ

Download 平成 28 30 - pmda.go.jp

The download button is on the right, sir!

Information

Domain:

Source:

Link to this page:

Please notify us if you found a problem with this document:

Spam notification

Thank you for your participation!

Submit notification

Broken preview notification

Thank you for your participation!

Submit notification

Other abuse

Documents from same domain

339 - pmda.go.jp

www.pmda.go.jp

医薬品・医療機器等安全性情報 No.339 −3− 2016年12月 1 ミルナシプラン塩酸塩，デュロキセチン塩酸塩及びベンラファキシン塩酸塩製剤の自動車運転等

Pmda

Report on the Deliberation Results - pmda.go.jp

www.pmda.go.jp

Report on the Deliberation Results . December 3, 2014 . Evaluation and Licensing Division, Pharmaceutical and Food Safety Bureau . Ministry of Health, Labour and Welfare

Report, Results, Report on the deliberation results, Deliberation

Filgrastim, Lenograstim, Nartograstim, Pegfilgrastim

www.pmda.go.jp

Pharmaceuticals and Medical Devices Agency This English version is intended to be a reference material for the convenience of users. In the event of

Pharmaceuticals and Medical Devices Safety …

www.pmda.go.jp

Pharmaceuticals and Medical Devices Safety Information No. 347 - 3 - October 2017 Abbreviations ADR Adverse drug reaction Alb Albumin ALP Alkaline phosphatase

Information, Devices, Pharmaceutical, Medical, Safety, Pharmaceuticals and medical devices safety, Pharmaceuticals and medical devices safety information

The Ministry of Health, Labour and Welfare …

www.pmda.go.jp

The Ministry of Health, Labour and Welfare Ministerial Notification No. 519 Pursuant to Paragraph 1, Article 41 of the Pharmaceutical AŠairs Law (Law No.

Labour, Welfare, Notification, Ministerial, Labour and welfare ministerial notification no

2018.3 No. 267 - pmda.go.jp

www.pmda.go.jp

1 2018. 3. dsu no. 267 重要生薬 510 サンシシ 2 漢方製剤 520 茵蔯蒿湯 3 温清飲 4 黄連解毒湯 3 加味帰脾湯 4

PMDA HP

www.pmda.go.jp

後発医薬品品質情報 no.9 4 独立行政法人医薬品医療機器総合機構（pmda）では、本誌情報やジェネリック医薬品品質情報検討会の

Pmda

PMDAからの医薬品適正使用のお願い - pmda.go.jp

www.pmda.go.jp

医薬品医療機器総合機構PMDA. からの医薬品適正使用のお願い http://www.pmda.go.jp/safety/info-services/drugs/0001.html

Info, Pmda

IMPURITIES GUIDELINE FOR RESIDUAL S Q3C(R5)

www.pmda.go.jp

international conference on harmonisation of technical requirements for registration of pharmaceuticals for human use ich harmonised tripartite guideline impurities: guideline for …

Guidelines, Impurities, Guideline for, Guideline impurities, Impurities guideline for

2.7.2 summary of clinical pharmacology Studies

www.pmda.go.jp

CONFIDENTIAL RM2003/00379/00 2.7.2 Summary of Clinical Pharmacology 4 ABBREVIATIONS 3TC lamivudine (EPIVIRƒ) ABC abacavir (ZIAGENƒ)AE Adverse Event AUC0-t,ss Area under the drug concentration-time curve from 0 to time t at steady state AUC∞ Area under the plasma concentration versus time curve from time 0 and …

Clinical, Summary, Pharmacology, 2 summary of clinical pharmacology, 2 summary of clinical pharmacology 4

Introductory Guide for MedDRA - WHO

www.who.int

This Introductory Guide is written in English and is intended only for use with the English version of MedDRA. Additional Introductory Guides have been developed to

Meddra